BNP and NT-proBNP levels in patients with sepsis

被引：19

作者：

Li, Nan ^{[1
]}

Zhang, Yu ^{[1
]}

Fan, Songtao ^{[2
]}

Xing, Jing ^{[1
]}

Liu, Hongyang ^{[1
]}

机构：

[1] Dalian Med Univ, Emergency Dept, Affiliated Hosp 1, Dalian 116011, Liaoning, Peoples R China

[2] Dalian Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Dalian 116011, Liaoning, Peoples R China

来源：

FRONTIERS IN BIOSCIENCE-LANDMARK | 2013年 / 18卷

关键词：

Systemic Inflammatory Response Syndrome; B-Type Natriuretic Peptide; Multiple Organ Dysfunction Syndrome; Atrial Natriuretic Peptide; Review; BRAIN NATRIURETIC PEPTIDE; C-REACTIVE PROTEIN; HEART-FAILURE; SEPTIC SHOCK; VENTRICULAR DYSFUNCTION; PROCALCITONIN; BIOCHEMISTRY; MARKER; EPIDEMIOLOGY; DEPRESSION;

D O I：

10.2741/4175

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Sepsis is a severe complication of critically ill patients that is characterized by the systemic inflammatory response syndrome (SIRS). The increased levels of B-type natriuretic peptide (BNP) and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) are related with dysfunction of the cardiovascular system and systemic inflammation. In recent years, BNP and NT-proBNP have been the focus of studies evaluating the severity and prognosis of sepsis. In this study, we will review the role of BNP and NT-proBNP in sepsis.

引用

页码：1237 / 1243

页数：7

共 58 条

[1]

Andrejaitiene Judita, 2006, Medicina (Kaunas), V42, P69

[2] Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].

Angus, DC ;

Linde-Zwirble, WT ;

Lidicker, J ;

Clermont, G ;

Carcillo, J ;

Pinsky, MR .

CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310

[3] B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress [J].

Bal, L ;

Thierry, S ;

Brocas, E ;

Van de Louw, A ;

Pottecher, J ;

Hours, S ;

Moreau, MH ;

Gachadoat, DP ;

Tenaillon, A .

ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2006, 50 (03) :340-347

[4] Procalcitonin Levels as an Early Marker in Patients with Multiple Trauma under Intensive Care [J].

Balci, C. ;

Sivaci, R. ;

Akbulut, G. ;

Karabekir, H. S. .

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2009, 37 (06) :1709-1717

[5]

Bertinchant JP, 2004, ARCH MAL COEUR VAISS, V97, P881

[6] Economic aspects of severe sepsis - A review of intensive care unit costs, cost of illness and cost effectiveness of therapy [J].

Burchardi, H ;

Schneider, H .

PHARMACOECONOMICS, 2004, 22 (12) :793-813

[7]

Cauliez B, 2005, ANN BIOL CLIN-PARIS, V63, P15

[8] Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis [J].

Charpentier, J ;

Luyt, CE ;

Fulla, Y ;

Vinsonneau, C ;

Cariou, A ;

Grabar, S ;

Dhainaut, JF ;

Mira, JP ;

Chiche, JD .

CRITICAL CARE MEDICINE, 2004, 32 (03) :660-665

[9] Clinical review: Myocardial depression in sepsis and septic shock [J].

Court, O ;

Kumar, A ;

Parrillo, JE ;

Kumar, A .

CRITICAL CARE, 2002, 6 (06) :500-508

[10] Anticoagulant properties of drotrecogin alfa (activated) during hemofiltration in patients with severe sepsis [J].

de Pont, Anne C. J. M. ;

Schultz, Marcus J. .

CRITICAL CARE, 2009, 13 (01)

← 1 2 3 4 5 6 →